These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 16256870)

  • 41. Testosterone Deficiency and Endothelial Dysfunction: Nitric Oxide, Asymmetric Dimethylarginine, and Endothelial Progenitor Cells.
    Hotta Y; Kataoka T; Kimura K
    Sex Med Rev; 2019 Oct; 7(4):661-668. PubMed ID: 30987932
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endogenous nitric oxide synthesis inhibitor asymmetric dimethyl L-arginine accelerates endothelial cell senescence.
    Scalera F; Borlak J; Beckmann B; Martens-Lobenhoffer J; Thum T; Täger M; Bode-Böger SM
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1816-22. PubMed ID: 15308550
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase and a novel cardiovascular risk molecule.
    De Gennaro Colonna V; Bianchi M; Pascale V; Ferrario P; Morelli F; Pascale W; Tomasoni L; Turiel M
    Med Sci Monit; 2009 Apr; 15(4):RA91-101. PubMed ID: 19333216
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease.
    Selley ML
    Neurobiol Aging; 2003 Nov; 24(7):903-7. PubMed ID: 12928048
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA.
    Sydow K; Mondon CE; Cooke JP
    Vasc Med; 2005 Jul; 10 Suppl 1():S35-43. PubMed ID: 16444867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension.
    Perticone F; Sciacqua A; Maio R; Perticone M; Maas R; Boger RH; Tripepi G; Sesti G; Zoccali C
    J Am Coll Cardiol; 2005 Aug; 46(3):518-23. PubMed ID: 16053968
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Asymmetric dimethylarginine (ADMA) elevation and arginase up-regulation contribute to endothelial dysfunction related to insulin resistance in rats and morbidly obese humans.
    El Assar M; Angulo J; Santos-Ruiz M; Ruiz de Adana JC; Pindado ML; Sánchez-Ferrer A; Hernández A; Rodríguez-Mañas L
    J Physiol; 2016 Jun; 594(11):3045-60. PubMed ID: 26840628
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Asymmetric dimethylarginine is increased in chronic thromboembolic pulmonary hypertension.
    Skoro-Sajer N; Mittermayer F; Panzenboeck A; Bonderman D; Sadushi R; Hitsch R; Jakowitsch J; Klepetko W; Kneussl MP; Wolzt M; Lang IM
    Am J Respir Crit Care Med; 2007 Dec; 176(11):1154-60. PubMed ID: 17872491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Asymmetric dimethylarginine, NO and collateral growth.
    Kocaman SA
    Anadolu Kardiyol Derg; 2009 Oct; 9(5):417-20. PubMed ID: 19819795
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2.
    Hasegawa K; Wakino S; Tatematsu S; Yoshioka K; Homma K; Sugano N; Kimoto M; Hayashi K; Itoh H
    Circ Res; 2007 Jul; 101(2):e2-10. PubMed ID: 17601800
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epigallocatechin gallate preserves endothelial function by reducing the endogenous nitric oxide synthase inhibitor level.
    Tang WJ; Hu CP; Chen MF; Deng PY; Li YJ
    Can J Physiol Pharmacol; 2006 Feb; 84(2):163-71. PubMed ID: 16900942
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preservation of vascular DDAH activity contributes to the protection of captopril against endothelial dysfunction in hyperlipidemic rabbits.
    Lin Y; Feng M; Lu CW; Lei YP; He ZM; Xiong Y
    Eur J Pharmacol; 2017 Mar; 798():43-48. PubMed ID: 28163022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Short communication: asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21-dependent mechanism.
    Fleissner F; Jazbutyte V; Fiedler J; Gupta SK; Yin X; Xu Q; Galuppo P; Kneitz S; Mayr M; Ertl G; Bauersachs J; Thum T
    Circ Res; 2010 Jul; 107(1):138-43. PubMed ID: 20489163
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dimethylarginine dimethylaminohydrolase promotes endothelial repair after vascular injury.
    Konishi H; Sydow K; Cooke JP
    J Am Coll Cardiol; 2007 Mar; 49(10):1099-105. PubMed ID: 17349891
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure.
    Feng Q; Lu X; Fortin AJ; Pettersson A; Hedner T; Kline RL; Arnold JM
    Cardiovasc Res; 1998 Mar; 37(3):667-75. PubMed ID: 9659450
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between asymmetric dimethylarginine and neopterin in patients with and without angiographic coronary artery disease.
    Murr C; Meinitzer A; Grammer T; Schroecksnadel K; Böhm BO; März W; Fuchs D
    Scand J Immunol; 2009 Jul; 70(1):63-7. PubMed ID: 19522769
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma concentrations of asymmetric dimethylarginine, nitric oxide and homocysteine in patients with slow coronary flow.
    Yucel H; Ozaydin M; Dogan A; Erdogan D; Turker Y; Ceyhan BM; Sutcu R
    Scand J Clin Lab Invest; 2012 Oct; 72(6):495-500. PubMed ID: 22950626
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endothelial progenitor cells and asymmetric dimethylarginine after renal transplantation.
    Teplan V; Mahrová A; Králová-Lesná I; Racek J; Valkovský I; Štollová M
    J Ren Nutr; 2015 Mar; 25(2):247-9. PubMed ID: 25576240
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis.
    Laufs U; Werner N; Link A; Endres M; Wassmann S; Jürgens K; Miche E; Böhm M; Nickenig G
    Circulation; 2004 Jan; 109(2):220-6. PubMed ID: 14691039
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma asymmetric dimethylarginine and coronary and peripheral endothelial dysfunction in hypertensive patients.
    Takiuchi S; Fujii H; Kamide K; Horio T; Nakatani S; Hiuge A; Rakugi H; Ogihara T; Kawano Y
    Am J Hypertens; 2004 Sep; 17(9):802-8. PubMed ID: 15363823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.